Skip to main content

Advertisement

Open Peer Review Reports for: FemZone trial: a randomized phase II trial comparing neoadjuvant letrozole and zoledronic acid with letrozole in primary breast cancer patients

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
14 Mar 2013 Submitted Original manuscript
14 Mar 2013 Author responded Author comments - Peter Fasching
Resubmission - Version 2
14 Mar 2013 Submitted Manuscript version 2
20 May 2013 Reviewed Reviewer Report - Adam Brufsky
2 Jun 2013 Reviewed Reviewer Report - Shunji Takahashi
6 Jun 2013 Reviewed Reviewer Report - Nigel Bundred
14 Jun 2013 Reviewed Reviewer Report - Judith R Kroep
26 Jul 2013 Author responded Author comments - Peter Fasching
Resubmission - Version 3
26 Jul 2013 Submitted Manuscript version 3
23 Dec 2013 Author responded Author comments - Peter Fasching
Resubmission - Version 4
23 Dec 2013 Submitted Manuscript version 4
Publishing
31 Jan 2014 Editorially accepted
5 Feb 2014 Article published 10.1186/1471-2407-14-66

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement